# Once-A-Day Prophylaxis for Youth and Young Adults With Severe Hemophilia A

> **NCT00717626** · PHASE2 · COMPLETED · sponsor: **The Hospital for Sick Children** · enrollment: 14 (actual)

## Conditions studied

- Hemophilia A

## Interventions

- **DRUG:** Kogenate FS, Advate, or Humate-P, Recombinate, Helixate FS

## Key facts

- **NCT ID:** NCT00717626
- **Lead sponsor:** The Hospital for Sick Children
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2020-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00717626

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00717626, "Once-A-Day Prophylaxis for Youth and Young Adults With Severe Hemophilia A". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00717626. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*